PD-L1 (CD274) promoter methylation predicts survival in patients with acute myeloid leukemia

D Goltz, H Gevensleben, S Grünen, J Dietrich… - Leukemia, 2017 - nature.com
In adult patients with acute myeloid leukemia (AML), short-term complete remission is
achieved with standard chemotherapy in the majority of cases. Long-term remission …
被引用次数：75 相关文章

PD-L1 (CD274) promoter methylation predicts survival in patients with acute myeloid leukemia.

D Goltz, H Gevensleben, S Grünen, J Dietrich… - Leukemia, 2017 - go.gale.com
In adult patients with acute myeloid leukemia (AML), short-term complete remission is
achieved with standard chemotherapy in the majority of cases. Long-term remission …

[引用][C] PD-L1 (CD274) promoter methylation predicts survival in patients with acute myeloid leukemia

D Goltz, H Gevensleben, S Grünen, J Dietrich… - Leukemia, 2016 - cir.nii.ac.jp
PD-L1 (CD274) promoter methylation predicts survival in patients with acute myeloid leukemia
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

[引用][C] PD-L1 (CD274) promoter methylation predicts survival in patients with acute myeloid leukemia.

D Goltz, H Gevensleben, S Grünen, J Dietrich… - Leukemia, 2016 - europepmc.org
PD-L1 (CD274) promoter methylation predicts survival in patients with acute myeloid leukemia.
- Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …

[引用][C] PD-L1 (CD274) promoter methylation predicts survival in patients with acute myeloid leukemia

D Goltz, H Gevensleben, S Grünen, J Dietrich… - …, 2017 - pubmed.ncbi.nlm.nih.gov
PD-L1 (CD274) promoter methylation predicts survival in patients with acute myeloid
leukemia PD-L1 (CD274) promoter methylation predicts survival in patients with acute …

PD-L1 (CD274) promoter methylation predicts survival in patients with acute myeloid leukemia

D Goltz, H Gevensleben, S Grunen, J Dietrich… - Leukemia, 2017 - go.gale.com
In adult patients with acute myeloid leukemia (AML), short-term complete remission is
achieved with standard chemotherapy in the majority of cases. Long-term remission …